Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Innova Captab Limited ( (IN:INNOVACAP) ).
Innova Captab Limited has scheduled a board meeting on 23 January 2026 to consider and approve its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, alongside a proposal for declaration of an interim dividend for the financial year 2025-26. If approved, the interim dividend will be paid to shareholders whose names appear on the company’s register or in depository records as of 30 January 2026, while the company has also confirmed closure of its trading window from 1 January 2026, to reopen 48 hours after the results are announced, underscoring its adherence to securities regulations and signaling a potentially shareholder-friendly capital allocation stance.
More about Innova Captab Limited
Innova Captab Limited is an India-based pharmaceuticals company engaged in manufacturing and marketing formulations, operating through both standalone and consolidated entities with its facilities located in industrial hubs such as Panchkula, Haryana, and a registered office in Navi Mumbai, Maharashtra. The company is listed on BSE and NSE under the symbol INNOVACAP and serves shareholders through equity listings on both major Indian exchanges.
Average Trading Volume: 2,678
Technical Sentiment Signal: Sell
Current Market Cap: 38.57B INR
See more data about INNOVACAP stock on TipRanks’ Stock Analysis page.